Recipient
Sensoreal Inc.Department
National Research Council CanadaAmount
$250.0K
Province
QCType
Contribution
Agreement Number
172-2020-2021-Q2-952810
Purpose
Current COVID-19 diagnostics are lacking a complete picture of the disease and have limited sensitivity. Sensoreal’s solution would be the first serological immunity test combined with direct detection of the virus from a nasal swab in an accurate and portable system. This solution adds the benefits of direct detection to the promise of immunity monitoring. The ideal diagnostic would not only limit the spread of the disease, but also help to manage it and foster long-term economic recovery.
Sensoreal Inc. × National Research Council Canada
13 grants totalling $3.4M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |